Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 446, 598-599 (5 April 2007) | doi:10.1038/446598a; Published online 4 April 2007
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Data Manager
- Philip Morris International (PMI)
- Neuchatel Switzerland
Academic Surgical Pathologists GI / Breast / GYN
- Medical College of Wisconsin
- Milwaukee, Wisconsin, USA
China's deadly drug problem
Top of page
Abstract
The head of China's drug-safety agency is under investigation for alleged corruption. David Cyranoski looks at how the inquiry might affect the country's fast-growing pharmaceutical industry.
A corruption scandal at China's top drug-regulatory agency has led to the arrest of its former head and an investigation of unprecedented scale into drugs approved during his tenure. Some are calling the crackdown a step towards a modernized drug industry that encourages innovation.
To read this story in full you will need to login or make a payment (see right).
